Supriya Lifescience Ltd. Reports Rs 145.07 Cr Revenue and 35.6% EBITDA Margin in Q1 FY26
Bengaluru, 18th August 2025 : The unaudited financial statements for the Q1FY26 results have been released by Supriya Lifescience Ltd., a cGMP-compliant business...
